Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:
PRODUCTS SPECIFICATIONS [4008-48-4]
Store
Catalog
SLK-S4591
Brand
Selleck
CAS
4008-48-4
DESCRIPTION [4008-48-4]
Overview
MDL
MFCD00006791
Molecular Weight
190.16
Molecular Formula
C9H6N2O3
SMILES
N(=O)(=O)C=1C2=C(C(O)=CC1)N=CC=C2
For research use only.
Storage
3 years,-20°C,powder 1 years,-80°C,in solvent
Shipping
Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)
Preparing Stock Solutions
1 mg
5 mg
10 mg
1 mM
5.2587 mL
26.2936 mL
52.5873 mL
5 mM
1.0517 mL
5.2587 mL
10.5175 mL
10 mM
0.5259 mL
2.6294 mL
5.2587 mL
50 mM
0.1052 mL
0.5259 mL
1.0517 mL
Description
Nitroxoline (8-Hydroxy-5-nitroquinoline, 5-nitroquinolin-8-ol, 5-Nitro-8-quinolinol, 5-Nitro-8-hydroxyquinoline) is a urinary antibacterial agent active against susceptible gram-positive and gram-negative organisms commonly found in urinary tract infections. Nitroxoline impairs tumor progression in vitro and in vivo by inhibiting activity.
Nitroxoline significantly reduces extracellular DQ-collagen IV degradation by all evaluated cancer cell lines using spectrofluorimetry. Nitroxoline also markedly decreases tumor cell invasion monitored in real time and reduces the invasive growth of multicellular tumor spheroids, used as a 3D in vitromodel of tumor invasion. Endothelial tube formation is significantly reduced by nitroxoline in an in vitro angiogenesis assay.
In vivo
Nitroxoline significantly abrogates tumor growth, angiogenesis and metastasis in vivo in LPB fibrosarcoma and MMTV-PyMT breast cancer mouse models.